GM1 gangliosidosis therapy（Sharp Therapeutics）
N/A
Report date: 2022/12/16 17:04:25
NME
Base Information
Drug NameGM1 gangliosidosis therapy（Sharp Therapeutics）
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSharp Therapeutics Pvt Ltd
China Registration ClassN/A
Develop Information
Active CompaniesSharp Therapeutics Pvt Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A